Relationship between adiponectin, obesity and insulin resistance - PubMed (original) (raw)
Review
. 2015 Jan-Feb;61(1):72-80.
doi: 10.1590/1806-9282.61.01.072. Epub 2015 Jan 1.
Affiliations
- PMID: 25909213
- DOI: 10.1590/1806-9282.61.01.072
Free article
Review
Relationship between adiponectin, obesity and insulin resistance
Guilherme Ardenghi Balsan et al. Rev Assoc Med Bras (1992). 2015 Jan-Feb.
Free article
Abstract
Objectives: the conditions of obesity and overweight pose a major risk for a number of comorbidities, including clinical syndromes resulting from atherosclerotic disease. Recent studies strongly indicate that adipose tissue is an active endocrine organ that secretes bioactive factors such as adipokines. Adiponectin appears to have a regulatory role in the mechanism of insulin resistance and in the development of atherosclerosis. This systematic review aims to evaluate the anti-atherogenic effects of adiponectin and its properties to improve and mimic metabolic and vascular actions of insulin and its influence on endothelial function.
Methods: a qualitative, exploratory and literature review was performed in the PubMed, Portal Capes and Scielo databases using as key-words "adiponectin", "obesity", "insulin resistance", "anti-inflammatory", "therapeutic strategies" and "future prospects".
Results: evidence suggests that adiponectin has anti-atherogenic properties with anti-inflammatory effects on the vascular wall. Moreover, it modifies the vascular intracellular signaling and has indirect antioxidant effects on the human myocardium. On the other hand, there are studies suggesting that increased levels of adiponectin are paradoxically associated with a worse prognosis in heart failure syndrome, although the mechanisms are not clear.
Conclusion: it is not clear whether adiponectin levels have any clinical significance for risk stratification in cardiovascular disease or if they simply reflect the activation of complex underlying mechanisms. Changes in lifestyle and some drug treatments for hypertension and coronary heart disease have shown significant effect to increase adiponectin levels, and simultaneously decrease in insulin resistance and endothelial dysfunction.
Similar articles
- Adiponectin: from obesity to cardiovascular disease.
Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C. Antoniades C, et al. Obes Rev. 2009 May;10(3):269-79. doi: 10.1111/j.1467-789X.2009.00571.x. Epub 2009 Mar 6. Obes Rev. 2009. PMID: 19389061 Review. - Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
Matsuda M, Shimomura I. Matsuda M, et al. Rev Endocr Metab Disord. 2014 Mar;15(1):1-10. doi: 10.1007/s11154-013-9271-7. Rev Endocr Metab Disord. 2014. PMID: 24026768 Review. - Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
Gable DR, Hurel SJ, Humphries SE. Gable DR, et al. Atherosclerosis. 2006 Oct;188(2):231-44. doi: 10.1016/j.atherosclerosis.2006.02.010. Epub 2006 Apr 3. Atherosclerosis. 2006. PMID: 16581078 Review. - Adiponectin and cardiovascular disease: response to therapeutic interventions.
Han SH, Quon MJ, Kim JA, Koh KK. Han SH, et al. J Am Coll Cardiol. 2007 Feb 6;49(5):531-8. doi: 10.1016/j.jacc.2006.08.061. Epub 2007 Jan 19. J Am Coll Cardiol. 2007. PMID: 17276175 Review. - Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. Bastard JP, et al. Eur Cytokine Netw. 2006 Mar;17(1):4-12. Eur Cytokine Netw. 2006. PMID: 16613757 Review.
Cited by
- Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest.
Petrocelli JJ, McKenzie AI, Mahmassani ZS, Reidy PT, Stoddard GJ, Poss AM, Holland WL, Summers SA, Drummond MJ. Petrocelli JJ, et al. J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1663-1670. doi: 10.1093/gerona/glaa072. J Gerontol A Biol Sci Med Sci. 2020. PMID: 32215553 Free PMC article. - Adipokine expression and endothelial function in subclinical hypothyroidism rats.
Gong N, Gao C, Chen X, Wang Y, Tian L. Gong N, et al. Endocr Connect. 2018 Feb;7(2):295-304. doi: 10.1530/EC-18-0007. Endocr Connect. 2018. PMID: 29440225 Free PMC article. - Aging effect on plasma metabolites and hormones concentrations in riding horses.
Kawasumi K, Yamamoto M, Koide M, Okada Y, Mori N, Yamamoto I, Arai T. Kawasumi K, et al. Open Vet J. 2015;5(2):154-7. Epub 2015 Nov 2. Open Vet J. 2015. PMID: 26623382 Free PMC article. - Combined treatment with a gastric inhibitory polypeptide receptor antagonist and a peptidyl peptidase-4 inhibitor improves metabolic abnormalities in diabetic mice.
Yang F, Dang S, Lv H, Shi B. Yang F, et al. J Int Med Res. 2021 Jan;49(1):300060520985664. doi: 10.1177/0300060520985664. J Int Med Res. 2021. PMID: 33512261 Free PMC article. - The Insulin-like Growth Factor Axis, Adipokines, Physical Activity, and Obesity in Relation to Breast Cancer Incidence and Recurrence.
Coughlin SS, Smith SA. Coughlin SS, et al. Cancer Clin Oncol. 2015;4(2):24-31. doi: 10.5539/cco.v4n2p24. Cancer Clin Oncol. 2015. PMID: 26251693 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical